ICCVS

ICCVS



The Centre is implementing a project entitled “International Centre for Cancer Vaccine Science”. Its activities are focused on personalised cancer immunotherapy. This approach is based on appropriate stimulation of a patient’s immune system to respond against cancer.

Project Creators

Prof. Natalia Marek-Trzonkowska
Prof. Natalia Marek-Trzonkowska
From 01.06.2021 prof. Natalia Marek-Trzonkowska is Acting Director of ICCVS. She leads the Cancer Immunology Group. Her research concerns clinical applications of cells of the immune system. Currently, she has been working on T cell based therapy for non-small cell lung cancer. She did her postdoctoral training at the University of Chicago, where she worked on pancreatic islet transplantation and conducted research on new methods for induction of immune tolerance. Awarded by numerous national and international boards, e.g. two Scientific Awards for research on the clinical application of regulatory T cells awarded by the European Federation of Immunological Societies (EFIS; Vienna and Glasgow), Polish-American Medical Society Award (PAMS; Chicago) and the Young Investigator Award granted by the International Society for Pediatric and Adolescent Diabetes (Istanbul), two scientific prizes awarded by the International Pancreas and Islet Transplant Association (IPITA; Praga) and Scholarship of the Minister of Science and Higher Education for Outstanding Young Scientists.

The founders of the ICCVS were initially Prof. Theodore Hupp and Prof. Robin Fahraeus. From June 1st, 2021, Prof. Hupp stepped down as the ICCVS director and group leader, while Prof. Fahraeus resigned from his position of group leader within the ICCVS from August 1st, 2021. Currently, Prof. Trzonkowska continues the work on the project.
Strategic partner


University of Edinburgh